Wednesday, March 8

Cardiacsense: CardiacSense receives approval from US-FDA and CDSCO

MedTech solutions provider Xplore Health has received approval from the Indian Regulatory Authority CDSCO (Central Drug Standard Control Organization) for its medical watch CardiacSense. The approval came ahead of its commercial launch in collaboration with Israeli Medtech company CardiacSense Ltd.
The product has already been approved by the USA’s FDA. CardiacSense technology is claimed to be designed to ensure that one is able to continuously monitor their Vital signs and whenever there is a notification raised by watch for increased or decreased heart rates or for Arrhythmias, watch prompts the user to take an ECG and share it instantly with the doctor for immediate advise.
Timely advise by doctors can make a huge difference in getting the right and timely treatments and avoid unnecessary hospitalisation or delays which lead to life threatening events.
CardiacSense is claimed to be one such device that will enable doctors and hospitals to monitor patients 24/7 who have recently undergone major surgeries or those suffering from chronic heart disease or organ failure.
CardiacSense medical watch comprises features like ECG and advanced vital sign. A prominent feature of this medical watch is said to be its capability to conduct ECG even remotely, which is being launched in India soon. According to the company, CardiacSense Medical Watch also can help people who are at risk of suffering from STROKE. It’s a known fact that Atrial Fibrillation, also called Afib (A kind of Arrhythmia), is responsible for increasing risk of Ischemic Stroke by over five times.
The watch is available in over 40 countries, including the USA, Europe, Australia, New Zealand, and other South American countries.

Source link

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *